Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Randomized controlled trial of a protein substitute with prolonged release on the protein status of children with phenylketonuria.
[phenylketonuria]
To
examine
whether
a
phenylalanine-free
protein
substitute
with
prolonged
release
may
be
beneficial
to
the
protein
status
of
children
with
phenylketonuria
(
PKU
)
compared
to
conventional
substitutes
.
Sixty
children
with
PKU
,
7
to
16
years
of
age
,
were
randomly
allocated
to
receive
either
a
prolonged
-release
(
test
)
or
the
current
conventional
protein
substitute
for
30
days
.
Subjects
were
additionally
sex
and
age
matched
with
60
subjects
with
mild
hyperphenylalaninemia
and
60
unaffected
subjects
.
The
protein
status
in
children
with
PKU
was
assessed
by
albumin
,
transthyretin
,
and
retinol-binding
protein
(
RBP
)
,
and
changes
throughout
the
trial
period
were
the
primary
outcome
measures
.
Children
with
PKU
did
not
differ
in
anthropometry
from
children
with
mild
hyperphenylalaninemia
or
unaffected
children
but
they
ingested
lower
amounts
of
proteins
(
p
<
0
.
01
)
.
No
differences
occurred
throughout
the
trial
between
or
within
children
with
PKU
who
received
the
test
or
conventional
substitute
for
macronutrient
intake
.
Albumin
and
RBP
concentrations
were
within
the
age-
specific
reference
range
for
all
children
.
The
rate
of
protein
insufficiency
(
transthyretin
concentration
less
than
20
mg
/
dL
)
did
not
differ
statistically
between
children
receiving
test
or
conventional
substitute
(
recruitment
51
.
8
%
vs
53
.
6
%
;
end
of
the
trial
44
.
4
%
vs
50
.
0
%
)
but
mean
transthyretin
recovered
over
20
mg
/
dL
in
children
who
received
the
test
substitute
,
increasing
from
19
.
1
to
20
.
7
mg
/
dL
(
mean
change
,
1
.
6
mg
/
dL
;
95
%
confidence
interval
0
.
4
to
2
.
8
mg
/
dL
)
.
In
children
receiving
conventional
substitute
mean
transthyretin
changed
from
19
.
0
to
19
.
2
mg
/
dL
(
0
.
2
;
-
0
.
2
to
0
.
6
)
mg
/
dL
.
Protein
substitutes
with
prolonged
release
might
be
beneficial
to
protein
status
in
children
with
phenylketonuria
.
Diseases
Validation
Diseases presenting
"primary outcome measures"
symptom
coats disease
phenylketonuria
zellweger syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom